广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | DSGN | Design Therapeutics Inc | 5.27 | 0.03% |
| 2024-12-31 | SANA | Sana Biotechnology Inc | 5.49 | 0.03% |
| 2024-12-31 | CDXS | Codexis Inc | 5.86 | 0.03% |
| 2024-12-31 | TNGX | Tango Therapeutics Inc | 5.01 | 0.03% |
| 2024-12-31 | RGNX | REGENXBIO Inc | 5.78 | 0.03% |
| 2024-12-31 | TRVI | Trevi Therapeutics Inc | 4.78 | 0.03% |
| 2024-12-31 | YMAB | Y-mAbs Therapeutics Inc | 5.29 | 0.03% |
| 2024-12-31 | ALMS | Alumis Inc | 5.6 | 0.03% |
| 2024-12-31 | AQST | Aquestive Therapeutics Inc | 4.9 | 0.03% |
| 2024-12-31 | NGNE | Neurogene Inc | 5.13 | 0.03% |
| 2024-12-31 | SLN | Silence Therapeutics plc ADR | 4.88 | 0.03% |
| 2024-12-31 | OLMA | Olema Pharmaceuticals Inc | 5.04 | 0.03% |
| 2024-12-31 | TSHA | Taysha Gene Therapies Inc | 5.35 | 0.03% |
| 2024-12-31 | CRVS | Corvus Pharmaceuticals Inc | 5.19 | 0.03% |
| 2024-12-31 | TVGN | Tevogen Bio Holdings Inc | 2.72 | 0.02% |
| 2024-12-31 | FHTX | Foghorn Therapeutics Inc | 3.96 | 0.02% |
| 2024-12-31 | FDMT | 4D Molecular Therapeutics Inc | 3.89 | 0.02% |
| 2024-12-31 | CMPS | COMPASS Pathways plc ADR | 2.9 | 0.02% |
| 2024-12-31 | NKTX | Nkarta Inc | 2.65 | 0.02% |
| 2024-12-31 | SCPH | scPharmaceuticals Inc | 2.67 | 0.02% |
公告&资料
